Please assess the completion status of the following clinical trial:

Trial Title: Topical 0.01% Atropine for the Control of Fast Progressing Myopia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Children from 4 to 12 years~* Myopia from -1 to -6~* Fast progressing myopia (\>0.75 diopter / year)~* Informed consent obtained~Exclusion Criteria:~Astigmatism \> 1.5 diopters~* Anisometropia \> 2 diopters~* Concomitant pathology of anterior or posterior segments~* Other ocular diseases (Ocular inflammation, strabismus ...)~* Atropine hypersensitivity or allergy

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Atropine 0.01% (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).